尿液外泌体中的分子脂质种类作为潜在的前列腺癌生物标志物
该研究采用高通量质谱定量脂质组学分析尿液外泌体的脂质组成,在15例前列腺癌患者和13例健康对照中定量36种最丰富的脂质种类,发现9种脂质水平在两组间有显著差异,其中磷脂酰丝氨酸18:1/18:1和乳糖神经酰胺(d18:1/16:0)显著性最高,后者患者与对照比值最高,这些脂质种类与PS 18:0-18:2组合区分两组达93%灵敏度和100%特异度。
要点
- 尿液外泌体中共定量107种脂质种类。
- 15例前列腺癌患者与13例健康对照相比,9种脂质种类水平有显著差异。
- 脂质组合区分两组达93%灵敏度和100%特异度。
核心结论
- 本研究首次显示尿液外泌体脂质种类作为前列腺癌生物标志物的潜在用途。
研究设计与样本
- 采用高通量质谱定量脂质组学分析尿液外泌体的脂质组成,纳入15例前列腺癌患者和13例健康对照。
主要发现
- 在尿液外泌体中共定量107种脂质种类。
- 在15例前列腺癌患者和13例健康对照中定量36种最丰富的脂质种类,发现9种脂质种类水平在两组间有显著差异。
- 磷脂酰丝氨酸18:1/18:1和乳糖神经酰胺(d18:1/16:0)显著性最高,后者患者与对照比值最高。
- 这些脂质种类与PS 18:0-18:2组合区分两组达93%灵敏度和100%特异度。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Exosomes have recently appeared as a novel source of noninvasive cancer biomarkers, since these nanovesicles contain molecules from cancer cells and can be detected in biofluids. We have here investigated the potential use of lipids in urinary exosomes as prostate cancer biomarkers. METHODS: A high-throughput mass spectrometry quantitative lipidomic analysis was performed to reveal the lipid composition of urinary exosomes in prostate cancer patients and healthy controls. RESULTS: Control samples were first analysed to characterise the lipidome of urinary exosomes and test the reproducibility of the method. In total, 107 lipid species were quantified in urinary exosomes. Several differences, for example, in cholesterol and phosphatidylcholine, were found between urinary exosomes and exosomes derived from cell lines, thus showing the importance of in vivo studies for biomarker analysis. The 36 most abundant lipid species in urinary exosomes were then quantified in 15 prostate cancer patients and 13 healthy controls. Interestingly, the levels of nine lipids species were found to be significantly different when the two groups were compared. The highest significance was shown for phosphatidylserine (PS) 18:1/18:1 and lactosylceramide (d18:1/16:0), the latter also showed the highest patient-to-control ratio. Furthermore, combinations of these lipid species and PS 18:0-18:2 distinguished the two groups with 93% sensitivity and 100% specificity. Finally, in agreement with the reported dysregulation of sphingolipid metabolism in cancer cells, alteration in specific sphingolipid lipid classes were observed. CONCLUSION: This study shows for the first time the potential use of exosomal lipid species in urine as prostate cancer biomarkers.
引用
- Skotland T, Ekroos K, Kauhanen D, et al. Molecular lipid species in urinary exosomes as potential prostate cancer biomarkers. Eur J Cancer. 2016. PMID: 27914242. doi:10.1016/j.ejca.2016.10.011
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。